How to fix CVE-2024-34398?

Within 30 days: Identify affected systems and apply vendor patches as part of regular patch cycle. Monitor vendor channels for patch availability.

Is Remedy Mid Tier affected by CVE-2024-34398?

CVE-2024-34398 presents moderate security risk rated CVSS 4.2. Exploitation could compromise the security of affected deployments. Organizations should apply vendor updates when available and monitor for exploitation.

Remedy Mid Tier CVE-2024-34398

MEDIUM

Basic XSS (CWE-80)

2025-03-12 [email protected]

XSS Remedy Mid Tier

4.2

CVSS 3.1

CVSS VectorNVD

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:N

Attack Vector

Network

Attack Complexity

High

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

Low

Integrity

Low

Availability

None

Lifecycle Timeline

Analysis Generated

Mar 28, 2026 - 18:31 vuln.today

CVE Published

Mar 12, 2025 - 17:15 nvd

MEDIUM 4.2

DescriptionNVD

An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by authenticated remote attackers.

AnalysisAI

An issue was discovered in BMC Remedy Mid Tier 7.6.04. Rated medium severity (CVSS 4.2), this vulnerability is remotely exploitable. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-80. An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by authenticated remote attackers. Affected products include: Bmc Remedy Mid-Tier.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.

CVE-2024-34398 vulnerability details – vuln.today

Back